Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2017 Publisher: Amdipharm UK Limited, Regency House, Miles Gray Road, Basildon, Essex, SS14 3AF, United Kingdom
Trasicor 20 mg Tablets.
Oxprenolol 20 mg Tablets.
| Pharmaceutical Form |
|---|
|
Film-coated tablets. White, round, biconvex, film-coated tablets, impressed OXP 20 on one face and no marking on the other. |
Each tablet contains 20 mg of oxprenolol hydrochloride.
Excipients with known effect:
Sucrose powder (86 mg/tablet)
Wheat starch (39.6 mg/tablet)
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Oxprenolol |
Oxprenolol is a non-selective, lipophilic betablocker exerting a sympatholytic effect and displaying mild to modest partial agonistic activity (PAA), also known as intrinsic sympathomimetic activity (ISA). Oxprenolol decreases cardiac impulse formation in the sinus node with resultant slowing of the sinus rate. |
| List of Excipients |
|---|
|
Calcium phosphate tribasic |
PVC* Blister packs of 56 and 100 tablets.
* PVC 250 micron, aluminium foil 20 micron.
Not all pack sizes may be marketed.
Amdipharm UK Limited, Regency House, Miles Gray Road, Basildon, Essex, SS14 3AF, United Kingdom
PL 20072/0018
Date of first authorisation: 1 January 2005
Date of latest renewal: 20 September 2005
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
